<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font19">the </span>
   <span class="font15">&amp;gt;. </span>
   <span class="font14">ZIKV </span>
   <span class="font14">were </span>
   <span class="font13">for </span>
   <span class="font13">with </span>
   <span class="font13">inhibitor </span>
   <span class="font13">based </span>
   <span class="font13">was </span>
   <span class="font12">(Table </span>
   <span class="font12">compounds </span>
   <span class="font12">SI-MTT </span>
   <span class="font12">cells </span>
   <span class="font12">SI-XTT </span>
   <span class="font12">activity </span>
   <span class="font11">potent </span>
   <span class="font11">Table </span>
   <span class="font11">Mycophenolic </span>
   <span class="font11">against </span>
   <span class="font11">antiviral </span>
   <span class="font11">identified </span>
   <span class="font11">virus </span>
   <span class="font11">Mycophenolate </span>
   <span class="font11">(Figure </span>
   <span class="font11">moderate </span>
   <span class="font11">weak </span>
   <span class="font11">Antimycin </span>
   <span class="font11">OSU- </span>
   <span class="font11">acid </span>
   <span class="font11">[]. </span>
   <span class="font11">Vero </span>
   <span class="font11">from </span>
   <span class="font11">{background </span>
   <span class="font11">Brequinar </span>
   <span class="font11">been </span>
   <span class="font11">has </span>
   <span class="font11">infected </span>
   <span class="font11">PRVABC </span>
   <span class="font11">post-treatment </span>
   <span class="font11">ÂµM) </span>
   <span class="font11">co-treatment </span>
   <span class="font11">infection </span>
   <span class="font11">treatment </span>
   <span class="font10">acid, </span>
   <span class="font10">MR- </span>
   <span class="font10">Zika </span>
   <span class="font10">inhibitors </span>
   <span class="font10">Azaribine, </span>
   <span class="font10">Obatoclax </span>
   <span class="font10">margin </span>
   <span class="font10">ten </span>
   <span class="font10">inhibit </span>
   <span class="font10">mofetil </span>
   <span class="font10">using </span>
   <span class="font10">virus, </span>
   <span class="font10">{border-style </span>
   <span class="font10">concentration </span>
   <span class="font10">effective </span>
   <span class="font10">mofetil, </span>
   <span class="font10">that </span>
   <span class="font10">viral </span>
   <span class="font10">(EC </span>
   <span class="font10">AVN- </span>
   <span class="font10">Obatoclax, </span>
   <span class="font10">inhibitory </span>
   <span class="font10">media </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">AVN-, </span>
   <span class="font10">Azaribine </span>
   <span class="font10">Azauridine, </span>
   <span class="font10">exhibited </span>
   <span class="font10">have </span>
   <span class="font10">Pyrazofurin, </span>
   <span class="font10">observed </span>
   <span class="font10">viruses </span>
   <span class="font10">Azauridine </span>
   <span class="font10">Paraiba/ </span>
   <span class="font10">Pyrazofurin </span>
   <span class="font10">The </span>
   <span class="font10">described </span>
   <span class="font10">their </span>
   <span class="font10">values </span>
   <span class="font10">Virus </span>
   <span class="font10">all </span>
   <span class="font10">also </span>
   <span class="font10">control </span>
   <span class="font10">included </span>
   <span class="font10">median </span>
   <span class="font10">pre-treatment </span>
   <span class="font10">replication </span>
   <span class="font10">tested </span>
   <span class="font10">these </span>
   <span class="font10">cell </span>
   <span class="font10">conducted </span>
   <span class="font10">containing </span>
   <span class="font10">results </span>
   <span class="font10">After </span>
   <span class="font10">Brequinar, </span>
   <span class="font10">MTT </span>
   <span class="font10">World </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cells, </span>
   <span class="font10">cells/well, </span>
   <span class="font10">concentration; </span>
   <span class="font10">concentrations </span>
   <span class="font10">each </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">independent </span>
   <span class="font10">indicated </span>
   <span class="font10">plate </span>
   <span class="font10">three </span>
   <span class="font10">ÂµM </span>
   <span class="font10">Aurintricarboxylic </span>
   <span class="font10">Catalog </span>
   <span class="font10">Inhibition </span>
   <span class="font10">No. </span>
   <span class="font10">USA), </span>
   <span class="font10">experiments </span>
   <span class="font10">format, </span>
   <span class="font10">previously </span>
   <span class="font10">treated </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(-well </span>
   <span class="font10">(CC-MTT </span>
   <span class="font10">DMSO </span>
   <span class="font10">Data </span>
   <span class="font10">Figure </span>
   <span class="font10">Viruses </span>
   <span class="font10">XTT </span>
   <span class="font10">assay </span>
   <span class="font10">assays, </span>
   <span class="font10">conditions </span>
   <span class="font10">drug </span>
   <span class="font10">evaluated </span>
   <span class="font10">had </span>
   <span class="font10">prophylactic </span>
   <span class="font10">repurposing </span>
   <span class="font10">strains </span>
   <span class="font10">synthesis </span>
   <span class="font10">used </span>
   <span class="font10">which </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(C) </span>
   <span class="font10">(D) </span>
   <span class="font10">(E) </span>
   <span class="font10">(F) </span>
   <span class="font10">(MTT) </span>
   <span class="font10">(SI-MTT </span>
   <span class="font10">CA, </span>
   <span class="font10">Res../j.antiviral... </span>
   <span class="font10">absorption, </span>
   <span class="font10">determined </span>
   <span class="font10">expressed </span>
   <span class="font10">mean </span>
   <span class="font10">quadruplicates) </span>
   <span class="font10">shown </span>
   <span class="font10">strain </span>
   <span class="font10">various </span>
   <span class="font10">(XTT) </span>
   <span class="font10">ATA </span>
   <span class="font10">Compounds </span>
   <span class="font10">RNA </span>
   <span class="font10">[,]. </span>
   <span class="font10">ability </span>
   <span class="font10">anti-ZIKV </span>
   <span class="font10">antivirals </span>
   <span class="font10">dehydrogenase </span>
   <span class="font10">index </span>
   <span class="font10">influenza </span>
   <span class="font10">px; </span>
   <span class="font10">pyrimidine </span>
   <span class="font10">showed </span>
   <span class="font10">starting </span>
   <span class="font10">values, </span>
   <span class="font10">{font-family </span>
   <span class="font10">ÂµM), </span>
   <span class="font10">ATA, </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Compound </span>
   <span class="font10">Dotted </span>
   <span class="font10">L.M.-S.; </span>
   <span class="font10">Louis, </span>
   <span class="font10">MO, </span>
   <span class="font10">Our </span>
   <span class="font10">St. </span>
   <span class="font10">USA) </span>
   <span class="font10">are </span>
   <span class="font10">compound </span>
   <span class="font10">compounds, </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">development </span>
   <span class="font10">dilutions, </span>
   <span class="font10">font-size </span>
   <span class="font10">incubated </span>
   <span class="font10">indicates </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibits </span>
   <span class="font10">into </span>
   <span class="font10">key </span>
   <span class="font10">line </span>
   <span class="font10">monophosphate </span>
   <span class="font10">new </span>
   <span class="font10">other </span>
   <span class="font10">selective </span>
   <span class="font10">vehicle </span>
   <span class="font10">viruses---t_Table </span>
   <span class="font10">Â°C </span>
   <span class="font10">(CC/EC). </span>
   <span class="font10">(DMEM </span>
   <span class="font10">(XTT)(ÂµM) </span>
   <span class="font10">.), </span>
   <span class="font10">CC, </span>
   <span class="font10">CC: </span>
   <span class="font10">Cell </span>
   <span class="font10">EC(ÂµM) </span>
   <span class="font10">EC: </span>
   <span class="font10">Group </span>
   <span class="font10">ReFRAME </span>
   <span class="font10">Results </span>
   <span class="font10">SI: </span>
   <span class="font10">USA). </span>
   <span class="font10">[], </span>
   <span class="font10">activities </span>
   <span class="font10">calculated </span>
   <span class="font10">double; </span>
   <span class="font10">fixed </span>
   <span class="font10">infection. </span>
   <span class="font10">its </span>
   <span class="font10">monolayers </span>
   <span class="font10">multiple </span>
   <span class="font10">pathway </span>
   <span class="font10">post-infection </span>
   <span class="font10">quadruplicates. </span>
   <span class="font10">respectively) </span>
   <span class="font10">strains. </span>
   <span class="font10">value </span>
   <span class="font10">when </span>
   <span class="font10">ÂµL </span>
   <span class="font10">(-folds </span>
   <span class="font10">(MTT)(ÂµM) </span>
   <span class="font10">All </span>
   <span class="font10">City, </span>
   <span class="font10">EC) </span>
   <span class="font10">FBS </span>
   <span class="font10">G.Ã�.-P., </span>
   <span class="font10">Influenza </span>
   <span class="font10">J.-G.P., </span>
   <span class="font10">S). </span>
   <span class="font10">Sigma-Aldrich, </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">action </span>
   <span class="font10">addition, </span>
   <span class="font10">anti-E </span>
   <span class="font10">assay, </span>
   <span class="font10">assays </span>
   <span class="font10">biosynthesis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">enzyme </span>
   <span class="font10">except </span>
   <span class="font10">following </span>
   <span class="font10">infections. </span>
   <span class="font10">inhibition. </span>
   <span class="font10">inosine </span>
   <span class="font10">library </span>
   <span class="font10">mAb. </span>
   <span class="font10">making </span>
   <span class="font10">not </span>
   <span class="font10">old </span>
   <span class="font10">post- </span>
   <span class="font10">pre- </span>
   <span class="font10">protein </span>
   <span class="font10">ranging </span>
   <span class="font10">reported </span>
   <span class="font10">respectively </span>
   <span class="font10">solid; </span>
   <span class="font10">supplemented </span>
   <span class="font10">then </span>
   <span class="font10">therapeutic </span>
   <span class="font10">triplicates) </span>
   <span class="font10">viruses, </span>
   <span class="font10">vitro </span>
   <span class="font10">where </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;gt;,. </span>
   <span class="font10">(ATA) </span>
   <span class="font10">(MOI </span>
   <span class="font10">(MR-) </span>
   <span class="font10">African </span>
   <span class="font10">Agents </span>
   <span class="font10">Caspase </span>
   <span class="font10">Cells </span>
   <span class="font10">DMEM </span>
   <span class="font10">DNA </span>
   <span class="font10">Drug </span>
   <span class="font10">ELISPOT </span>
   <span class="font10">Effect </span>
   <span class="font10">FBS) </span>
   <span class="font10">MEX-- </span>
   <span class="font10">MR-, </span>
   <span class="font10">Manassas, </span>
   <span class="font10">New </span>
   <span class="font10">PSG </span>
   <span class="font10">Paraiba/. </span>
   <span class="font10">Plaques </span>
   <span class="font10">Potent </span>
   <span class="font10">Union </span>
   <span class="font10">VA, </span>
   <span class="font10">any </span>
   <span class="font10">automated </span>
   <span class="font10">bold </span>
   <span class="font10">can </span>
   <span class="font10">candidate </span>
   <span class="font10">cells. </span>
   <span class="font10">compound, </span>
   <span class="font10">condition, </span>
   <span class="font10">conditions, </span>
   <span class="font10">confluent </span>
   <span class="font10">counted </span>
   <span class="font10">courier; </span>
   <span class="font10">culture </span>
   <span class="font10">data </span>
   <span class="font10">developing </span>
   <span class="font10">disease </span>
   <span class="font10">due </span>
   <span class="font10">em; </span>
   <span class="font10">highest </span>
   <span class="font10">human </span>
   <span class="font10">immunostaining </span>
   <span class="font10">infections, </span>
   <span class="font10">levels </span>
   <span class="font10">maximal </span>
   <span class="font10">measured </span>
   <span class="font10">media. </span>
   <span class="font10">number </span>
   <span class="font10">post-treatment, </span>
   <span class="font10">pt;} </span>
   <span class="font10">reader. </span>
   <span class="font10">rejection </span>
   <span class="font10">respectively), </span>
   <span class="font10">strains, </span>
   <span class="font10">suggest </span>
   <span class="font10">supernatants </span>
   <span class="font10">supporting </span>
   <span class="font10">through </span>
   <span class="font10">toxicity </span>
   <span class="font10">viability </span>
  </p>
 </body>
</html>
